Table 1.

Distribution of V gene mutations in anti-HCV E2 hybridomas

HybridomasVH GermlineHomology (%)R:S mutationsScarcity of R mutation in FRsExcess of R mutation in CDRs
FRsCDRs
CBH4B VH1-69 90.8 8:8 9:1 P = .00300* P = .00925* 
CBH4D VH1-69 93.3 8:3 3:5 P = .08676 P = .00011* 
CBH4G VH1-69 92.9 5:5 7:3 P = .00176* P = .02163* 
CBH5 VH1-69 88.3 9:11 11:2 P = .00022* P = .00247* 
CBH7 VH1-69 90.8 9:10 6:1 P = .00925* P = .00019* 
CBH8E VH1-69 96.4 3:3 5:2 P = .00691* P = .08563 
CBH11 VH1-e 91.5 8:5 4:7 P = .00864* P = .00002* 
CBH2 VH5-51 94.3 6:4 6:0 P = .04465* P = .04465* 
CBH8C VH4-59 92.8 1:7 9:3 P = .00001* P = .15227 
CBH17 VH3-73 88.8 11:10 10:1 P = .00592* P = .00204* 
HybridomasVH GermlineHomology (%)R:S mutationsScarcity of R mutation in FRsExcess of R mutation in CDRs
FRsCDRs
CBH4B VH1-69 90.8 8:8 9:1 P = .00300* P = .00925* 
CBH4D VH1-69 93.3 8:3 3:5 P = .08676 P = .00011* 
CBH4G VH1-69 92.9 5:5 7:3 P = .00176* P = .02163* 
CBH5 VH1-69 88.3 9:11 11:2 P = .00022* P = .00247* 
CBH7 VH1-69 90.8 9:10 6:1 P = .00925* P = .00019* 
CBH8E VH1-69 96.4 3:3 5:2 P = .00691* P = .08563 
CBH11 VH1-e 91.5 8:5 4:7 P = .00864* P = .00002* 
CBH2 VH5-51 94.3 6:4 6:0 P = .04465* P = .04465* 
CBH8C VH4-59 92.8 1:7 9:3 P = .00001* P = .15227 
CBH17 VH3-73 88.8 11:10 10:1 P = .00592* P = .00204* 
HybridomasVL GermlineHomology (%)R:S mutationsScarcity of R mutation in FRsExcess of R mutation in CDRs
FRsCDRs
CBH4B Vk3-A27 95.4 3:3 4:2 P = .01085* P = .07773 
CBH4D Vλ2-2a2 95.6 6:3 3:0 P = .31691 P = .24510 
CBH4G Vk1-A20 98.5 0:0 4:0 P = .01350* P = .00026* 
CBH5 Vk1-L12 94.3 1:7 5:2 P = .00001* P = .05436 
CBH7 Vk1-O12 96.2 6:2 1:1 P = .89335 P = .97264 
CBH8E Vk1-O12 97.3 0:4 3:0 P = .01453* P = .42831 
CBH11 Vk1-L12 96.2 1:6 5:0 P = .00017* P = .02039* 
CBH2 Vk3-A27 96.2 1:2 5:2 P = .00110* P = .00848* 
CBH8C Vk3-L6 98.1 1:1 3:0 P = .05049 P = .01699* 
CBH17 Vλ3-3h 90.9 10:4 8:2 P = .05545 P = .01976* 
HybridomasVL GermlineHomology (%)R:S mutationsScarcity of R mutation in FRsExcess of R mutation in CDRs
FRsCDRs
CBH4B Vk3-A27 95.4 3:3 4:2 P = .01085* P = .07773 
CBH4D Vλ2-2a2 95.6 6:3 3:0 P = .31691 P = .24510 
CBH4G Vk1-A20 98.5 0:0 4:0 P = .01350* P = .00026* 
CBH5 Vk1-L12 94.3 1:7 5:2 P = .00001* P = .05436 
CBH7 Vk1-O12 96.2 6:2 1:1 P = .89335 P = .97264 
CBH8E Vk1-O12 97.3 0:4 3:0 P = .01453* P = .42831 
CBH11 Vk1-L12 96.2 1:6 5:0 P = .00017* P = .02039* 
CBH2 Vk3-A27 96.2 1:2 5:2 P = .00110* P = .00848* 
CBH8C Vk3-L6 98.1 1:1 3:0 P = .05049 P = .01699* 
CBH17 Vλ3-3h 90.9 10:4 8:2 P = .05545 P = .01976* 

The probability (P) that excess or scarcity of replacement (R) mutations in CDRs and in FRs resulted only by chance was calculated using the multinominal distribution model.24 

*

Significant.

Close Modal

or Create an Account

Close Modal
Close Modal